As we close out another calendar year, we look back at the top legal developments of 2021 that could influence the market for biologics and biosimilars. There were many interesting decisions and other developments in district...more
12/28/2021
/ AbbVie ,
Antitrust Litigation ,
Biosimilars ,
Fresenius ,
Generic Drugs ,
International Trade Commission (ITC) ,
Johnson & Johnson ,
Mylan Pharmaceuticals ,
Orange Book ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Pfizer ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Popular ,
Prescription Drugs ,
Proposed Legislation ,
Sanofi ,
Sherman Act ,
The Clayton Act
The domestic industry requirement at the U.S. International Trade Commission (ITC or Commission) continued to evolve in three significant opinions in 2014. In one opinion, the Commission set forth a nexus requirement for...more